Sign in

CIK 0001157601

  • Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 267-824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
  1. 4 Open-market buy Director bought 85,900 shares at an average $3.15 ($270,477)
  2. 4 Open-market buy President and CEO bought 10,000 shares at $3.05 ($30,530)
  3. 4 Open-market buy Director bought 115,292 shares at an average $2.90 ($333,777)
  4. 4 Grant or award VP, IP and Legal, Gen. Counsel acquired 5,284 shares (grant or award)
  5. 4 Grant or award VP, Fin. and Admin., CFO acquired 5,284 shares (grant or award)
  6. 4 Grant or award SVP, Chief Medical Officer acquired 7,477 shares (grant or award)
  7. 4 Grant or award Sr. VP, Drug Development acquired 8,224 shares (grant or award)
  8. 4 Grant or award Sr. VP, Pgm Mgmt and Clin Ops acquired 7,908 shares (grant or award)
  9. 4 Grant or award Sr. VP, Chief Comm. Officer acquired 8,627 shares (grant or award)
  10. 4 Grant or award President and CEO acquired 13,839 shares (grant or award)
  11. 5/A Insider Annual Insider Trading Report
  12. 5/A Insider Annual Insider Trading Report
  13. 5 Insider Annual Insider Trading Report
  14. 5 Insider Annual Insider Trading Report
  15. 4 Open-market buy Director bought 550,000 shares at $4.50 ($2,475,000)
  16. 4 Open-market buy Director bought 100,000 shares at $4.50 ($450,000)
  17. 4 Open-market buy Director bought 100,000 shares at $4.50 ($450,000)
  18. 4 Open-market buy President and CEO bought 22,222 shares at $4.50 ($99,999)
  19. 4 Open-market buy Sr. VP, Drug Development bought 10,000 shares at $2.84 ($28,434)
  20. 4 Open-market buy 10% owner bought 20,000 shares at $2.88 ($57,600)

Page 24 of 29 · 564 filings